HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Suzanne Eccles Selected Research

ErbB Receptors (EGF Receptor)

6/2003Targeting of cells expressing wild-type EGFR and type-III mutant EGFR (EGFRvIII) by anti-EGFR MAb ICR62: a two-pronged attack for tumour therapy.
8/2002A synthetic matrix metalloproteinase inhibitor prevents squamous carcinoma cell proliferation by interfering with epidermal growth factor receptor autocrine loops.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Suzanne Eccles Research Topics

Disease

14Neoplasms (Cancer)
06/2023 - 02/2002
3Breast Neoplasms (Breast Cancer)
06/2023 - 02/2002
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2011 - 08/2002
2Hypoxia (Hypoxemia)
12/2017 - 04/2009
2Squamous Cell Carcinoma of Head and Neck
03/2011 - 08/2002
2Ovarian Neoplasms (Ovarian Cancer)
06/2007 - 07/2002
2Carcinoma (Carcinomatosis)
07/2005 - 07/2004
1Cholangiocarcinoma
01/2018
1Colorectal Neoplasms (Colorectal Cancer)
08/2013
1Melanoma (Melanoma, Malignant)
03/2009
1Glioblastoma (Glioblastoma Multiforme)
03/2009
1Prostatic Neoplasms (Prostate Cancer)
02/2002

Drug/Important Bio-Agent (IBA)

2Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2019 - 07/2005
2Phosphotransferases (Kinase)IBA
01/2019 - 01/2013
2Biomarkers (Surrogate Marker)IBA
12/2017 - 06/2007
2tanespimycin (17AAG)IBA
08/2013 - 03/2009
2PI103IBA
08/2013 - 06/2007
2LigandsIBA
08/2013 - 08/2002
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2011 - 04/2009
2ErbB Receptors (EGF Receptor)IBA
06/2003 - 08/2002
1Cholecalciferol (Vitamin D3)FDA Link
06/2023
1involucrinIBA
06/2023
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
06/2023
1Differentiation AntigensIBA
06/2023
1Calcitriol (Calcijex)FDA LinkGeneric
06/2023
1Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2018
1Complement System Proteins (Complement)IBA
01/2018
1Antineoplastic Agents (Antineoplastics)IBA
01/2018
1protolichesterinic acidIBA
10/2014
1Fatty Acid Synthases (Fatty Acid Synthase)IBA
10/2014
1Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
08/2013
1tyrosine receptor (receptor, tyrosine)IBA
01/2013
1CytokinesIBA
03/2011
1Vascular Endothelial Growth Factor DIBA
03/2011
1Vascular Endothelial Growth Factor CIBA
03/2011
1furanIBA
04/2009
1NSC 652287IBA
04/2009
1Tumor Suppressor Protein p53IBA
04/2009
1Syk KinaseIBA
08/2007
1LipidsIBA
06/2007
1RoscovitineIBA
07/2005
1lissamine rhodamine B (sulforhodamine B)IBA
07/2005
1olomoucineIBA
07/2005
1bohemineIBA
07/2005
1CalciumIBA
07/2004
1Hormones (Hormone)IBA
07/2004
1Sigma-1 ReceptorIBA
07/2004
1Phosphatidylinositols (Phosphatidylinositol)IBA
07/2004
1Type C PhospholipasesIBA
07/2004
1sigma Receptors (sigma Receptor)IBA
07/2004
1Monoclonal AntibodiesIBA
06/2003
1epidermal growth factor receptor VIIIIBA
06/2003
1EpitopesIBA
06/2003
1marimastatIBA
08/2002
1Transforming Growth Factor alpha (TGF-alpha)IBA
08/2002
1Matrix Metalloproteinases (MMPs)IBA
08/2002
1heregulin beta1IBA
08/2002
1Matrix Metalloproteinase InhibitorsIBA
08/2002
1Epidermal Growth Factor (EGF)IBA
08/2002
1BetacellulinIBA
08/2002
1Paclitaxel (Taxol)FDA LinkGeneric
07/2002
1Cisplatin (Platino)FDA LinkGeneric
07/2002
1geldanamycinIBA
07/2002
1Hyaluronoglucosaminidase (Hyaluronidase)FDA Link
02/2002
1Messenger RNA (mRNA)IBA
02/2002

Therapy/Procedure

3Therapeutics
01/2013 - 06/2003
2Drug Therapy (Chemotherapy)
01/2018 - 12/2017
1Radiotherapy
12/2017